Introduction
============

Ca^2+^ and cAMP are two of a limited number of intracellular messengers used by cells to regulate a diverse array of cellular events in response to many different extracellular stimuli. The specificity of these messengers is provided by the spatio-temporal organization of their concentration changes within cells ([@B1][@B2; @B3][@B4]) and by complex interactions between them ([@B2], [@B5], [@B6]). In addressing the means whereby parathyroid hormone (PTH)[^3^](#FN4){ref-type="fn"} regulates release of Ca^2+^ from intracellular stores, we have shown that PTH acts entirely via cAMP to increase the sensitivity of IP~3~ receptors (IP~3~R) to IP~3~, thereby potentiating the Ca^2+^ signals evoked by other receptors that stimulate IP~3~ formation ([@B7]). This effect of PTH is not mediated by the common targets of cAMP, PKA, and exchange proteins activated by cAMP (epac), but results instead from cAMP binding directly to a low affinity site on either the IP~3~R itself or a protein tightly associated with it ([@B7]). These results identify the IP~3~R as a new target for regulation by cAMP and so reveal another site at which cAMP and Ca^2+^ signaling pathways interact. The results also highlighted the importance of the precise spatial relationship between adenylyl cyclase (AC) and IP~3~R, because cAMP appears to pass directly and selectively from type 6 AC (AC6) to the type 2 IP~3~R (IP~3~R2) via an association that we termed an AC·IP~3~R junction ([@B7]) ([Fig. 1](#F1){ref-type="fig"}*A*).

These observations led us to define two forms of local cAMP signaling ([Fig. 1](#F1){ref-type="fig"}*A*). The first mode, represented by the AC·IP~3~R junction, is binary signaling. Here, cAMP is delivered directly to its target at very high concentrations by a closely associated AC; cAMP then switches the target on in all-or-nothing fashion. The second mode is analog signaling, where targets further away from AC, like PKA and exchange proteins activated by cAMP, respond to graded changes in cAMP concentration. The low affinity of the IP~3~R for cAMP ensures that diffusion of cAMP is probably sufficient to terminate a response and insulate one junction from its neighbors. For analog signaling, local degradation of cAMP by associated cyclic nucleotide phosphodiesterases is required to terminate the response and maintain the spatial organization of cAMP signaling ([Fig. 1](#F1){ref-type="fig"}*A*) ([@B7], [@B8]).

Here, we address two further questions related to cAMP signaling to IP~3~R. First, although we have shown that, in intact HEK cells the effects of PTH are selectively mediated by IP~3~R2, it is unclear whether this results solely from a selective association of IP~3~R2 with AC6, or whether IP~3~R2 is also unique among the three IP~3~R subtypes in responding to cAMP. We demonstrate, using IP~3~R1--3 expressed in DT40 cells lacking native IP~3~R, that all IP~3~R subtypes are regulated by cAMP itself. Second, although AC6 and IP~3~R2 are associated in a signaling complex (the AC6·IP~3~R2 junction, [Fig. 1](#F1){ref-type="fig"}*A*), it is unclear whether other components of the signaling pathway linking PTH receptors to sensitization of IP~3~R are also uniquely associated with individual AC6·IP~3~R junctions. By selectively inhibiting Gα~s~ expression using stably expressed shRNA, we demonstrate that Gα~s~ is probably also specifically associated with AC·IP~3~R junctions.

EXPERIMENTAL PROCEDURES
=======================

### 

#### Cells and Vectors

HEK 293 cells stably transfected with human type 1 PTH receptor (HEK-PR1 cells) were cultured as described ([@B9]). A modified pSUPER vector ([@B10]) was used for shRNA-mediated knockdown of Gα~s~ in HEK-PR1 cells. An expression cassette for blasticidin resistance from pcDNA6/TR (Invitrogen) was cloned upstream of the polymerase-III H1-RNA promoter of pSUPER to generate a pSUPERBlank vector. Primers 1 and 2 for human Gα~s~ (see [supplemental Table S1](http://www.jbc.org/cgi/content/full/M109.096016/DC1) for primer sequences) were annealed, phosphorylated by T4 polynucleotide kinase (New England Biolabs), and ligated into the BglII-HindIII sites of pSUPERBlank to create the pSUPERGα~s~ vector. The plasmids, pSUPERBlank and pSUPERGα~s~, were linearized and transfected into HEK-PR1 cells (5 μg of DNA/10^6^ cells) using Transfast^TM^ Reagent (Promega). Transfected cells were selected using blasticidin (10 μg/ml) and G418 (800 μg/ml). Clonally isolated cells were screened for Gα~s~ by immunoblotting using a Gα~s~ antiserum (RM/1, 1:1000, New England Nuclear). Appropriate clones were further propagated for use in assays of cAMP and \[Ca^2+^\]*~i~*.

DT40 cells in which each IP~3~R gene had been disrupted (DT40KO cells) ([@B11]) were cultured as described ([@B12]). The ORF of rat IP~3~R1 (GenBank^TM^ accession number [GQ233032.1](GQ233032.1)) was amplified by PCR from the expression vector pCMVI-9-IP~3~R1 ([@B13]) using primers 3 and 4 ([supplemental Table S1](http://www.jbc.org/cgi/content/full/M109.096016/DC1)), and cloned as an EcoRI fragment into pENTR1a vector (Invitrogen). The ORF of mouse IP~3~R2 (GenBank^TM^ accession number [AB182290](AB182290)) was amplified by PCR as two fragments from the expression vector pcDNA3-IP~3~R2 ([@B14]). The 5′ fragment (1--3297) was amplified by PCR using primers 5 and 6 and cloned as a SalI-XhoI fragment into pENTR1a. Then the entire ORF (1--8196) was amplified by PCR using primers 5 and 7, digested with KpnI and XhoI, and the resulting fragment (2230--8196) was cloned into pENTR1a. Finally, a SalI-BstBI fragment (1--2711) from the first construct was cloned into the second construct (replacing the smaller SalI-BstBI fragment) to give the entire ORF (1--8196) of mouse IP~3~R2 in pENTR1a. [Supplemental Experimental Procedures](http://www.jbc.org/cgi/content/full/M109.096016/DC1) provide further details of the cloning and expression of IP~3~R2. The ORF of rat IP~3~R3 (GenBank^TM^ accession number [GQ233031.1](GQ233031.1)) was amplified by PCR from the expression vector pCB6-IP~3~R3 ([@B15]) using primers 8 and 9, and cloned as an EcoRI fragment into pENTR1a vector (Invitrogen). Each pENTR1a-IP~3~R construct was recombined with pcDNA3.2/V5-DEST (Invitrogen) to generate the Gateway-compatible expression vectors pcDNA3.2-IP~3~R1 (2 and 3). DT40KO cells were transfected by nucleofection with linearized constructs of pcDNA3.2-IP~3~R1 (2 or 3) using solution T and program B23 (Amaxa) using 5 μg of DNA/10^6^ cells. G418 (2 mg/ml) was used to select and amplify clones of cells. Expression of IP~3~R in each cell line was quantified by immunoblotting using an anti-peptide antiserum (AbC ([@B16])) that interacts equally with all three IP~3~R subtypes. GeneTools (Syngene) was used to quantify band intensities on immunoblots. To estimate numbers of IP~3~R in each DT40 cell line, immunoblots were calibrated using membranes prepared from rat cerebellum in which the receptor density (*B*~max~) had been measured by equilibrium competition \[^3^H\]IP~3~ binding.

For expression of mouse IP~3~R2 in Sf9 cells, pENTR1a-IP~3~R2 was recombined with Gateway-compatible BaculoDirect C-Term linear DNA (Invitrogen) to generate a recombinant baculovirus using the BaculoDirect^TM^ C-Term expression kit (Invitrogen). Sf9 cells were cultured as previously described ([@B17]), they were then infected with the recombinant virus DNA, and the virus was isolated according to the manufacturer\'s instructions (Invitrogen). For IP~3~R2 expression, cells were infected at a multiplicity of infection of 10.

#### Measurements of IP~3~-evoked Ca^2+^ Release from Permeabilized Cells

The intracellular stores of DT40 cells stably expressing mammalian IP~3~R were loaded with Mag-fluo-4 to allow measurement of the luminal-free \[Ca^2+^\] ([@B12]). Cells were then permeabilized by incubation with saponin (10 μg/ml) and immobilized in 96-well plates to allow continuous monitoring of the Ca^2+^ content of the intracellular stores using a FlexStation fluorescence plate reader (MDS Analytical Devices) ([@B12]). All experiments were performed at 20 °C in cytosol-like medium with a free \[Ca^2+^\] of 220 n[m]{.smallcaps} (CLM: 140 m[m]{.smallcaps} KCl, 20 m[m]{.smallcaps} NaCl, 1 m[m]{.smallcaps} EGTA, 375 μ[m]{.smallcaps} CaCl~2~, 20 m[m]{.smallcaps} Pipes, pH 7.0). MgATP (1.5 m[m]{.smallcaps}) was added to allow Ca^2+^ uptake into the stores, and when steady-state loading had been achieved, IP~3~ was added with thapsigargin (1 μ[m]{.smallcaps}) to allow Ca^2+^ release to be measured without further re-uptake. IP~3~-evoked Ca^2+^ release is expressed as a fraction of the Ca^2+^ released by addition of ionomycin (1 μ[m]{.smallcaps}) ([@B12]). Similar methods were used to measure IP~3~-evoked Ca^2+^ release from Sf9 cells expressing IP~3~R2.

#### Binding of ^3^H-IP~3~ to IP~3~R2

Membranes were prepared from Sf9 cells expressing mouse IP~3~R2 as described ([@B17]). Briefly, cells were harvested 60 h after infection, washed, and resuspended in Ca^2+^-free CLM supplemented with complete protease inhibitor mixture (Roche Applied Science, 1 tablet/25 ml). The suspension (3 × 10^7^ cells/ml) was homogenized and centrifuged (130,000 × *g*, 60 min), and the pellet was resuspended in Ca^2+^-containing CLM and stored at −80 °C. Membranes (72 μg of protein/ml) were resuspended in CLM (0.5 ml, supplemented with 2 m[m]{.smallcaps} MgCl~2~) containing \[^3^H\]IP~3~ (1.5 n[m]{.smallcaps}, 18 Ci/mmol) and appropriate concentrations of unlabeled IP~3~. Variations in the composition of CLM at different steps were dictated by the need to minimize proteolysis during lysis (bivalent cation-free CLM) and then to include both Ca^2+^ and Mg^2+^ in the \[^3^H\]binding assay more effectively to mimic the composition of cytosol and for comparison with our previous analyses of \[^3^H\]IP~3~ binding to IP~3~R1 and IP~3~R3 ([@B16]).

After 5 min at 2 °C, during which equilibrium was attained, the incubations were stopped by addition of γ-globulin (30 μl, 25 mg/ml) and polyethylene glycol 8000 (500 μl, 30%). After centrifugation (20,000 × *g* for 5 min at 2 °C), pellets were dissolved in Triton X-100 (200 μl, 2%), and ^3^H activity was determined by liquid scintillation counting after addition of Ecoscint A scintillation mixture (1 ml, National Diagnostics). Total \[^3^H\]IP~3~ binding was typically 2300 dpm, of which ∼90% was specific binding. Results were fitted to Hill equations (GraphPad Prism, version 5) from which the half-maximal inhibitory concentration, and thereby the *K~D~*, were determined.

#### Measurements of cAMP and \[Ca^2+^\]*~i~* in Intact Cells

HEK-PR1 cells in 96-well plates were cultured for 2--3 days until almost confluent, washed, loaded with fluo-4, and \[Ca^2+^\]*~i~* was then measured using a FlexStation fluorescence plate reader as described before ([@B7]). All experiments were performed at 20 °C in HBS or Ca^2+^-free HBS. HBS had the following composition: 135 m[m]{.smallcaps} NaCl, 5.9 m[m]{.smallcaps} KCl, 1.2 m[m]{.smallcaps} MgCl~2~, 1.5 m[m]{.smallcaps} CaCl~2~, 11.6 m[m]{.smallcaps} HEPES, 11.5 m[m]{.smallcaps} glucose, pH 7.3; Ca^2+^-free HBS was supplemented with 10 m[m]{.smallcaps} BAPTA.

Single cell analyses of \[Ca^2+^\]*~i~* in fura-2-loaded HEK-PR1 cells were performed as previously reported, with fluorescence ratios calibrated, after correction for background fluorescence, to \[Ca^2+^\]*~i~* by reference to Ca^2+^-calibration solutions ([@B18]).

For assays of cAMP, HEK-PR1 cells in 24-well plates were cultured for 2--3 days (as above) until near confluence and then stimulated under identical conditions to those used for measurements of \[Ca^2+^\]*~i~*; the only difference was the omission of fluo-4-AM and Pluronic F-127 from the 1-h loading incubation. Cell extracts were prepared, and their cAMP content was determined by radioimmunoassay using acetylated standards prepared from a cAMP stock calibrated by its UV absorption (ϵ~258~ = 14,100) as described ([@B7], [@B19]). It is important to note that single cell measurements of \[Ca^2+^\]*~i~* established that 98% of cells responded to CCh, and 99% of those responded to PTH ([@B7]). This observation justifies our use of cell populations for comparisons of the effects of stimuli on \[Ca^2+^\]*~i~* and cAMP levels.

#### Nuclear Patch Clamp Recording

Currents were recorded from patches excised from the outer nuclear envelope of DT40-KO cells stably expressing mouse IP~3~R2, using Cs^+^ as the charge carrier. Bath and pipette (PS) solutions had the following composition: 200 m[m]{.smallcaps} CsCH~3~SO~3~, 500 μ[m]{.smallcaps} BAPTA, 211 μ[m]{.smallcaps} CaCl~2~ (free \[Ca^2+^\] = 200 n[m]{.smallcaps}), 10 m[m]{.smallcaps} HEPES, pH 7.2 (with CsOH). Where appropriate, IP~3~, cAMP, and/or ATP were included in PS. Data were collected and analyzed exactly as described previously ([@B20]).

#### Analysis

Concentration-effect relationships for each experiment were individually fitted to Hill equations using non-linear curve-fitting (GraphPad Prism, version 5), and the results obtained from each (EC~50~, Hill coefficient *h*, and maximal response) were pooled for analysis and presentation. For simplicity, EC~50~ values are reported as means ± S.E., although log EC~50~ values were used for statistical analysis. Student\'s *t* test or one-way analysis of variance followed by post hoc Bonferroni test were used as appropriate.

#### Materials

Sources of materials not specified herein are provided in a previous study ([@B7]).

RESULTS AND DISCUSSION
======================

### 

#### Potentiation of IP~3~-evoked Ca^2+^ Release by cAMP

CCh, which activates phospholipase C and thus IP~3~ formation via endogenous muscarinic acetylcholine receptors, stimulated Ca^2+^ release from the intracellular stores of HEK-PR1 cells ([Fig. 1](#F1){ref-type="fig"}*B*). The response was potentiated by forskolin, which activates AC directly ([@B7]), or by PTH, which activates AC via heterologously expressed type 1 PTH receptors and the G-protein, G~s~ ([Fig. 1](#F1){ref-type="fig"}*B*). The effect of PTH on CCh-evoked Ca^2+^ release was mimicked by a membrane-permeant analogue of cAMP, 8-Br-cAMP (EC~50~ = 324 μ[m]{.smallcaps}) ([@B7]), and the sensitivity to 8-Br-cAMP was unaffected by H89 at a concentration (10 μ[m]{.smallcaps}) sufficient to inhibit fully PKA-mediated protein phosphorylation ([Fig. 1](#F1){ref-type="fig"}*C*) ([@B7]). Neither forskolin nor 8-Br-cAMP alone evoked Ca^2+^ release ([@B7]).

![**PTH potentiates CCh-evoked Ca^2+^ release via a direct effect of cAMP on IP~3~R.** *A*, binary and analog modes of cAMP signaling ([@B7]). *AKAP*, protein kinase A-anchoring protein; *PM*, plasma membrane. Further details are in text. *B*, populations of HEK-PR1 cells in Ca^2+^-free HBS were stimulated with CCh alone (1 m[m]{.smallcaps}, *black line*) or with PTH (100 n[m]{.smallcaps}, 60 s) followed by CCh (*gray line*). Results are typical of at least three similar experiments. *C*, HEK-PR1 cells were preincubated (20 min) with the indicated concentrations of 8-Br-cAMP alone or with H89 (10 μ[m]{.smallcaps}) ([@B7]) before stimulation with a submaximal concentration of CCh (1 μ[m]{.smallcaps}). Results show the increase in \[Ca^2+^\]*~i~* evoked by the CCh addition. *D*, IP~3~-evoked Ca^2+^ release from permeabilized HEK-PR1 cells in the presence of submaximal (1 m[m]{.smallcaps}) or maximal (10 m[m]{.smallcaps}) concentrations of cAMP after preincubation with or without H89 (10 μ[m]{.smallcaps}; 20 min). Results (*C* and *D*) show means ± S.E., *n* = 3 independent experiments.](zbc0211014470001){#F1}

In permeabilized HEK-PR1 cells, IP~3~ stimulated release of Ca^2+^ from the intracellular stores, cAMP increased the sensitivity to IP~3~, and the effects of cAMP were again unaffected by inhibition of PKA ([Fig. 1](#F1){ref-type="fig"}*D*). These results confirm our earlier conclusion that in HEK-PR1 cells, PTH potentiates IP~3~-evoked Ca^2+^ release via cAMP and with no requirement for PKA ([@B7]). The earlier work established that IP~3~R2 and AC6 are selectively associated and both are required for PTH to potentiate CCh-evoked Ca^2+^ signals ([@B7]) ([Fig. 1](#F1){ref-type="fig"}*A*). But it is not yet clear whether the specific requirement for IP~3~R2 derives entirely from its association with AC6 or is IP~3~R2 also the only subtype of IP~3~R to respond directly to cAMP?

#### Regulation of All IP~3~R Subtypes by cAMP

IP~3~ stimulated release of Ca^2+^ from the intracellular stores of permeabilized DT40 cells stably expressing mammalian IP~3~R1, IP~3~R2, or IP~3~R3 ([Fig. 2](#F2){ref-type="fig"}*A*), but not from the parental cells lacking endogenous IP~3~R (not shown) ([@B21], [@B22]). Because the three IP~3~R subtypes are not expressed at identical levels ([Fig. 2](#F2){ref-type="fig"}*B* and [Table 1](#T1){ref-type="table"}), we cannot assume that the different fractions of the intracellular Ca^2+^ stores released by a maximal concentration of IP~3~ or the different EC~50~ values ([Table 1](#T1){ref-type="table"}) directly reflect specific properties of the three IP~3~R subtypes. It is generally suggested that IP~3~R2 is more sensitive than IP~3~R1 to IP~3~, and both are considerably more sensitive than IP~3~R3 ([@B23], [@B24]). However, in our assays of DT40 cells stably expressing a single IP~3~R subtype we found the order of sensitivity to be: IP~3~R1 \> IP~3~R2 ≫ IP~3~R3 ([Table 1](#T1){ref-type="table"}). The slightly lower than anticipated sensitivity of cells expressing IP~3~R2 probably results from IP~3~R2 being expressed at a lower level (∼30--40%) than the other subtypes ([Table 1](#T1){ref-type="table"}) ([@B21]). The ∼5-fold difference in IP~3~ sensitivity between cells expressing IP~3~R1 and IP~3~R3 does not detract from our ability to resolve the effects of cAMP on IP~3~-evoked Ca^2+^ release via each IP~3~R subtype.

![**cAMP potentiates IP~3~-evoked Ca^2+^ release by the three subtypes of IP~3~R.** *A*, IP~3~-evoked Ca^2+^ release from the intracellular stores of DT40 cells expressing only IP~3~R1, IP~3~R2, or IP~3~R3. *B*, immunoblots (with AbC) show levels of IP~3~R expression in each of the three cell lines (95 μg of protein/*lane*) compared with membranes from rat cerebellum (1.1 and 0.2 μg/*lane*); the position of the 220-kDa *M*~r~ marker is shown. The blot is typical of six experiments from two different preparations. Summary results are shown in [Table 1](#T1){ref-type="table"}. *C*, typical results from permeabilized DT40 cells expressing the indicated IP~3~R incubated with ATP (added at the *first arrow*) to allow loading of the intracellular Ca^2+^ stores, before addition (*second arrow*) of cAMP alone (*i*, 1 m[m]{.smallcaps}), IP~3~ alone (*ii*, 30 n[m]{.smallcaps} for IP~3~R1 and IP~3~R2; 300 n[m]{.smallcaps} for IP~3~R3), or IP~3~ with cAMP (*iii*). Each *trace* is the average of three to four wells from a single experiment and is representative of results from three to four independent experiments. *D*, from experiments similar to those shown in *C*, the concentration-dependent effects of cAMP on the EC~50~ for IP~3~-evoked Ca^2+^ release are shown for each IP~3~R subtype. Results are means ± S.E., *n* ≥ 3.](zbc0211014470002){#F2}

###### 

**Responses of IP~3~R subtypes to IP~3~ and cAMP**

Permeabilized DT40 cells expressing only a single mammalian IP~3~R subtype were used to examine the sensitivity of the intracellular Ca^2+^ stores to IP~3~ (EC~50~) and the fraction of the stores released by a maximally effective concentration of IP~3~. For each cell line, IP~3~R expression was quantified using immunoblotting with AbC ([Fig. 2](#F2){ref-type="fig"}*B*), which interacts equally with all three IP~3~R subtypes ([@B16]) and calibrated against a stock of rat cerebellar membranes for which *B*~max~ (tetrameric IP~3~R/10^6^ cells) had been determined from \[^3^H\]IP~3~ binding. The effects of a maximally effective concentration of cAMP on the EC~50~ for IP~3~-evoked Ca^2+^ release are shown, derived from experiments similar to those shown in [Figs. 1](#F1){ref-type="fig"}*D* and [2](#F2){ref-type="fig"}. The sensitivity to cAMP is shown by the EC~50~ for the effects of cAMP on IP~3~-evoked Ca^2+^ release. Results are means ± S.E. (*n* ≥ 3).

                                                   IP~3~R1     IP~3~R2     IP~3~R3     IP~3~R2-ΔATPB
  ------------------------------------------------ ----------- ----------- ----------- ----------------------------------------
  IP~3~R expression (fmol/10^6^ cells)             38 ± 2      16 ± 1      56 ± 5      ND[^*a*^](#TF1-1){ref-type="table-fn"}
  EC~50~ for IP~3~ (n[m]{.smallcaps})              56 ± 3      74 ± 10     255 ± 9     246 ± 17
  EC~50~ for IP~3~ after cAMP (n[m]{.smallcaps})   13 ± 1      22 ± 1      134 ± 19    44 ± 3
  Fold stimulation by cAMP                         4.2 ± 0.1   3.3 ± 0.3   2.0 ± 0.3   5.7 ± 0.6
  Maximum response to IP~3~ (%)                    83 ± 10     80 ± 1      80 ± 1      45 ± 4
  Maximum response to IP~3~ after cAMP (%)         79 ± 2      81 ± 1      82 ± 1      53 ± 4
  EC~50~ for cAMP (μ[m]{.smallcaps})               642 ± 158   267 ± 80    361 ± 74    ND

*^a^* ND, not determined.

We used the three DT40 cell lines to examine the effects of cAMP on IP~3~-evoked Ca^2+^ release. The results demonstrate that cAMP alone had no effect on the intracellular Ca^2+^ stores ([Fig. 2](#F2){ref-type="fig"}*C*), but it significantly increased the sensitivity of each IP~3~R subtype to IP~3~ ([Fig. 2](#F2){ref-type="fig"}, *C* and *D*). For all subtypes, a maximally effective concentration of cAMP caused the EC~50~ for IP~3~-evoked Ca^2+^ release to decrease by between 2- and 4-fold ([Table 1](#T1){ref-type="table"}). This increase in sensitivity is similar to the ∼3-fold increased sensitivity to CCh of HEK-PR1 cells treated with PTH ([@B7]), but less than the ∼7-fold increase in IP~3~ sensitivity evoked by a maximal concentration of cAMP in permeabilized HEK cells ([Fig. 1](#F1){ref-type="fig"}*D*). There was no statistical difference (*p* \< 0.05) between either the sensitivities of the three IP~3~R subtypes to cAMP (EC~50~) or the Hill coefficients of the concentration-effect relationships. We conclude that the three subtypes of IP~3~R are similarly sensitive to cAMP, with EC~50~ values between ∼300 and 650 μ[m]{.smallcaps} ([Table 1](#T1){ref-type="table"}).

#### Interactions of cAMP with IP~3~R2

Our earlier work established the importance of IP~3~R2 in mediating responses to PTH ([@B7]) and responses of homomeric IP~3~R2 are potentiated by cAMP ([Fig. 2](#F2){ref-type="fig"}, *C* and *D*), we therefore focused on this IP~3~R subtype for our further analyses of the interactions of cAMP with IP~3~R.

It proved impracticable to measure \[^3^H\]IP~3~ binding in CLM to membranes prepared from DT40-IP~3~R2 cells; we therefore used membranes from Sf9 cells expressing the same mouse IP~3~R2 ([Fig. 3](#F3){ref-type="fig"}*A*). We first confirmed that IP~3~R2 expressed in Sf9 cells are regulated by cAMP. Whereas IP~3~ (10 μ[m]{.smallcaps}) stimulated release of only 7 ± 1% (EC~50~ = 500 ± 50 n[m]{.smallcaps}) of the Ca^2+^ stores of uninfected Sf9 cells, it released 30 ± 4% (EC~50~ = 122 ± 35 n[m]{.smallcaps}) of the stores from permeabilized Sf9 cells expressing mouse IP~3~R2 ([Fig. 3](#F3){ref-type="fig"}*B*). This confirms that most IP~3~-evoked Ca^2+^ release from the infected Sf9 cells is mediated by heterologously expressed IP~3~R2. Treatment with cAMP (1 m[m]{.smallcaps}), which itself caused no Ca^2+^ release, increased the sensitivity of the expressed IP~3~R2 to IP~3~: the EC~50~ was reduced from 122 ± 35 n[m]{.smallcaps} to 41 ± 12 n[m]{.smallcaps} ([Fig. 3](#F3){ref-type="fig"}*B*). These results establish that IP~3~R2 expressed in Sf9 cells, like those expressed in HEK ([@B7]) or DT40 cells ([Fig. 2](#F2){ref-type="fig"}), are sensitized to IP~3~ by cAMP.

![**Interaction of cAMP with IP~3~R2 expressed in Sf9 cells.** *A*, immunoblot (with AbC) showing expression of IP~3~R2 in membranes from infected Sf9 cells, but not from membranes of uninfected cells (control). Protein loadings are shown in micrograms. *B*, concentration-dependent release by IP~3~ of Ca^2+^ from permeabilized Sf9 cells expressing mouse IP~3~R2 with or without addition of cAMP (1 m[m]{.smallcaps}). *C*, specific binding of \[^3^H\]IP~3~ (1.5 n[m]{.smallcaps}) to membranes from Sf9 cells expressing mouse IP~3~R2 in the presence of the indicated concentrations of unlabeled IP~3~. There was no detectable specific binding of \[^3^H\]IP~3~ to membranes from uninfected cells. Because the concentration of \[^3^H\]IP~3~ (1.5 n[m]{.smallcaps}) was less than the *K~D~* for IP~3~ (4.3 n[m]{.smallcaps}), a change in *K~D~* or *B*~max~ would be reflected in the specific \[^3^H\]IP~3~ binding. The *open circle* shows that cAMP (10 m[m]{.smallcaps}) had no effect on specific \[^3^H\]IP~3~ binding. Results (*B* and *C*) show means ± S.E., *n* ≥ 3.](zbc0211014470003){#F3}

IP~3~ bound to IP~3~R2 expressed in Sf9 cells with high affinity (*K~D~* = 4.30 ± 0.04 n[m]{.smallcaps}, B~max~ = 2.55 pmol/mg), but specific binding of \[^3^H\]IP~3~ (1.5 n[m]{.smallcaps}) was unaffected by cAMP (10 m[m]{.smallcaps}) ([Fig. 3](#F3){ref-type="fig"}*C*). This demonstrates that the effect of cAMP on IP~3~R2 is not mediated by an increase in its affinity for IP~3~, but must instead result from an increase in the effectiveness with which IP~3~ binding is coupled to channel opening; cAMP increases the efficacy of IP~3~.

#### Effects of cAMP on Single IP~3~R2

In patch clamp recordings from excised nuclear patches of DT40-IP~3~R2 cells, IP~3~ (100 μ[m]{.smallcaps}) in the absence of ATP (which is not required for high concentrations of IP~3~ to maximally activate IP~3~R2 ([@B25])) stimulated opening of large-conductance cation channels (γ~Cs~ ∼200 pS, [Fig. 4](#F4){ref-type="fig"}, *A*, *i*, and *ii*, and *B*). These channels were absent from the nuclei of DT40-KO cells ([Fig. 4](#F4){ref-type="fig"}*A*, *iii*). The single channel open probability (*P*~o~) of these IP~3~R was similar (*P*~o~ = 0.49 ± 0.07) ([Fig. 4](#F4){ref-type="fig"}*A*, *ii*) to that reported for maximally stimulated IP~3~R2 expressed in the plasma membrane ([@B25]), or nuclear IP~3~R1 and IP~3~R3 ([@B20]). The latter recordings used K^+^ as charge-carrier, but *P*~o~ for IP~3~R1 is similar whether K^+^ (*P*~o~ = 0.45 ± 0.07) or Cs^+^ (*P*~o~ = 0.41 ± 0.04) is used as the charge carrier. These results establish that 100 μ[m]{.smallcaps} IP~3~ in the absence of ATP maximally activates IP~3~R2.

![**Effects of cAMP on single channel activities of IP~3~R2.** *A*, *traces* show excised nuclear patch clamp recordings from DT40-IP~3~R2 (*i* and *ii*) or DT40-KO cells (*iii*) in which IP~3~ (100 μ[m]{.smallcaps}) was included in PS as indicated. *B*, current-voltage (*i-V*) relationship for single IP~3~R2 stimulated with IP~3~ (1 μ[m]{.smallcaps}), with or without cAMP (1 m[m]{.smallcaps}) in PS. The single channel slope conductances (γ~Cs~) were 204 ± 6 and 200 ± 12 pS in the absence and presence of cAMP, respectively. *C*, typical *traces* from single IP~3~R2 stimulated with submaximal IP~3~ (1 μ[m]{.smallcaps}) in the presence and absence of cAMP (1 m[m]{.smallcaps}) and/or ATP (5 m[m]{.smallcaps}) in PS as indicated. *D*, from recordings similar to those shown in *D*, *NP*~o~ is shown for IP~3~R2 stimulated as indicated. Note the use of *NP*~o~ to report channel activity here because the IP~3~Rs are less active in some of the recording conditions, making it difficult to determine reliably the number of IP~3~R in each patch (see text). For all *traces*, PS contained a free \[Ca^2+^\] of 200 n[m]{.smallcaps}, the holding potential was +40 mV, *C* denotes the closed state, and each *trace* is typical of at least three similar recordings. Results (*B* and *D*) are means ± S.E., *n* ≥ 3.](zbc0211014470004){#F4}

The effects of cAMP are most evident in Ca^2+^ release assays after submaximal activation with IP~3~ ([Fig. 1](#F1){ref-type="fig"}*D* and [Table 1](#T1){ref-type="table"}) ([@B7]). Our initial examination of the effects of cAMP on single IP~3~R2 were therefore performed without ATP and with a submaximal concentration of IP~3~. Because *P*~o~ is much lower under these conditions, it is impossible to resolve with confidence the number of active IP~3~R within a patch ([@B20]) and so impossible to calculate *P*~o~. We therefore use *NP*~o~ (the overall channel activity) to report the activity of IP~3~R in these submaximally stimulated patches. A concentration of cAMP (1 m[m]{.smallcaps}) sufficient to sensitize maximally IP~3~-evoked Ca^2+^ release ([Fig. 2](#F2){ref-type="fig"}*D*) had no effect alone on channel activity recorded from nuclei of DT40-IP~3~R2 cells ([Fig. 4](#F4){ref-type="fig"}*C*, *i*). But cAMP significantly increased the activity of IP~3~R2 stimulated with a submaximal concentration of IP~3~ (1 μ[m]{.smallcaps}): *NP*~o~ increased from 0.06 ± 0.02 (*n* = 11) in the absence of cAMP to 0.18 ± 0.05 (*n* = 5) in its presence ([Fig. 4](#F4){ref-type="fig"}, *C*, *ii* and *iii*, and *D*). The single channel Cs^+^ conductance was unaffected by cAMP ([Fig. 4](#F4){ref-type="fig"}*B*). Because these experiments were performed in the absence of ATP, the effects of cAMP cannot be attributed to PKA-mediated phosphorylation of IP~3~R.

In keeping with work from others ([@B25]), ATP (5 m[m]{.smallcaps}) alone had no effect on IP~3~R2 activity (not shown), but it potentiated responses to a submaximal concentration of IP~3~ (1 μ[m]{.smallcaps}): *NP*~o~ increased from 0.06 ± 0.02 (*n* = 11) to 0.15 ± 0.02 (*n* = 5) in the presence of ATP ([Fig. 4](#F4){ref-type="fig"}, *C*, *ii*, and *iv*, and *D*). In the presence of this maximally effective concentration of ATP ([@B25]), cAMP (1 m[m]{.smallcaps}) further potentiated responses to IP~3~ (1 μ[m]{.smallcaps}): *NP*~o~ increased from 0.15 ± 0.02 to 0.41 ± 0.05 (*n* = 6) in the presence of cAMP ([Fig. 4](#F4){ref-type="fig"}, *C*, *iv* and *v*, and *D*). In keeping with our results from Ca^2+^ release assays ([Table 1](#T1){ref-type="table"}), cAMP did not increase *NP*~o~ of IP~3~R2 stimulated with a maximally effective concentration of IP~3~ (100 μ[m]{.smallcaps}): *NP*~o~ was 0.49 ± 0.07 and 0.51 ± 0.1 (*n* = 3) in the absence and presence of cAMP, respectively ([Fig. 4](#F4){ref-type="fig"}*D*). We conclude that cAMP, either directly or via a tightly associated accessory protein, increases the activity of IP~3~R2 stimulated with IP~3~.

#### cAMP Potentiation of IP~3~-evoked Ca^2+^ Release Is Not Mediated by the Modulatory ATP-binding Site

We further considered the possibility that the effects of cAMP might reflect its interaction with the site(s) through which ATP potentiates IP~3~R function ([@B25], [@B26]). This seems unlikely from the results of our single channel analyses ([Fig. 4](#F4){ref-type="fig"}) and because cAMP potentiates responses to IP~3~ in the presence of 1.5 m[m]{.smallcaps} ATP ([Fig. 2](#F2){ref-type="fig"}, *C* and *D*), which others have shown to be more than sufficient to potentiate maximally responses to IP~3~ ([@B25]). Yule and co-workers have established that an ATP-binding site in IP~3~R2 (ATPB, residues 1969--1974) mediates modulation of IP~3~R2 gating by ATP. Mutation of glycine residues (G1969A, G1971A, and G1974A) within this site abolishes the potentiating effect of ATP on IP~3~-evoked Ca^2+^ release ([@B25]). We used the same cell line (DT40-ΔATPB), kindly provided by David Yule (University of Rochester), to examine the effects of cAMP on IP~3~-evoked Ca^2+^ release. Responses to IP~3~ in these DT40-ΔATPB cells were also potentiated by cAMP ([Fig. 5](#F5){ref-type="fig"}, *A* and *B*, and [Table 1](#T1){ref-type="table"}). These results, together with those from single channel analyses ([Fig. 4](#F4){ref-type="fig"}), establish that the effects of cAMP on IP~3~R2 are not mediated by its interaction with the site through which ATP potentiates activity.

![**Potentiation of IP~3~R2 by cAMP does not require the ATPB-binding site.** *A*, typical results from permeabilized DT40 cells expressing only IP~3~R2-ΔATPB incubated with ATP (added at the *first arrow*) before addition (*second arrow*) of cAMP alone (*i*, 3 m[m]{.smallcaps}), IP~3~ alone (*ii*, 300 n[m]{.smallcaps}), or IP~3~ with cAMP (*iii*). Each *trace* is the average of three to four wells from one experiment and is representative of results from three independent experiments. *B*, summary showing the concentration-dependent effects of IP~3~ on Ca^2+^ release in the absence and presence of cAMP (3 m[m]{.smallcaps}). Results are means ± S.E., *n* ≥ 3.](zbc0211014470005){#F5}

#### PKA-dependent and -independent Regulation of IP~3~R by cAMP

All three IP~3~R subtypes respond directly to cAMP ([Fig. 2](#F2){ref-type="fig"}), all three can also be phosphorylated, at multiple sites, by PKA ([@B6], [@B7], [@B27][@B28; @B29; @B30; @B31; @B32; @B33][@B34]), and substantial evidence suggests that the phosphorylation can modulate IP~3~R activity ([@B28], [@B31], [@B35][@B36; @B37][@B38]). Phosphorylation of IP~3~R1 by PKA increases their activity ([@B27], [@B31], [@B32], [@B39][@B40][@B41]). An initial suggestion that PKA inhibits IP~3~R1 probably resulted from a counteracting stimulatory effect of PKA on Ca^2+^ re-uptake ([@B30]). IP~3~R2 appears to be a rather poor substrate for PKA ([@B7], [@B27], [@B28], [@B36]), although it is phosphorylated at Ser-937 ([@B34]), and in cells expressing predominantly IP~3~R2, PKA typically causes a very modest increase in their sensitivity to IP~3~ ([@B7], [@B28], [@B35], [@B42]). In DT40 cells expressing only IP~3~R2 forskolin enhances responses to IP~3~, but the extent to which this requires activation of PKA is unclear. When a PKA-selective analog of cAMP was used, phosphorylation of Ser-937 by PKA was required for potentiation of the Ca^2+^ signals evoked by threshold concentrations of CCh ([@B34]). Clearly, therefore, PKA can both phosphorylate and modestly sensitize IP~3~R2; the extent to which that underlies the effects of forskolin or cAMP is unresolved. The effects of PKA on IP~3~R3 are less clear. Analyses from cells in which IP~3~R3 is the major subtype suggest that PKA either modestly sensitizes them to IP~3~ ([@B28]) or attenuates their responses ([@B33], [@B43]). The only published analysis of homomeric IP~3~R3 expressed in DT40 cells concluded that PKA had no effect on IP~3~-evoked Ca^2+^ release ([@B27]).

Under conditions where the catalytic subunit of PKA (200 units/ml for 10 min) phosphorylates IP~3~R in HEK-PR1 cells ([@B7]), it had no effect on IP~3~-evoked Ca^2+^ release from DT40 cells expressing IP~3~R2 ([Fig. 6](#F6){ref-type="fig"}*A*) or IP~3~R3 (not shown), and it only very modestly increased the sensitivity of IP~3~R1 to IP~3~ (the EC~50~ fell from 36 to 27 n[m]{.smallcaps} ([supplemental Fig. S1](http://www.jbc.org/cgi/content/full/M109.096016/DC1), *A* and *B*). We note that, even for IP~3~R1, where the effects of PKA are relatively uncontentious, phosphorylation by PKA typically increases the IP~3~ sensitivity by \<2-fold ([@B28], [@B36], [@B40]). In our analyses of HEK-PR1 cells also, the very modest stimulatory effect of PKA on IP~3~-evoked Ca^2+^ release (∼30%) is much smaller than that of cAMP (∼450%) ([@B7]).

![**Sensitization of IP~3~R2 by cAMP does not require activation of PKA.** *A*, IP~3~-evoked Ca^2+^ release from the intracellular stores of permeabilized DT40-IP~3~R2 cells with and without preincubation with the catalytic subunit of PKA (200 units/ml, 10 min). *B*, Ca^2+^ release from permeabilized DT40-IP~3~R2 cells stimulated with IP~3~ alone (60 n[m]{.smallcaps}) or in combination with cAMP (3 m[m]{.smallcaps}) after the indicated pretreatments (10 min) with the catalytic subunit of PKA (200 units/ml) and/or H89 (10 μ[m]{.smallcaps}). Results are means ± S.E., *n* ≥ 3.](zbc0211014470006){#F6}

In an attempt to reduce phosphorylation by endogenous PKA ([@B41]), we first incubated DT40-IP~3~R2 cells with H89 (10 μ[m]{.smallcaps}, 60 min) to inhibit PKA before permeabilizing the cells and assessing their responses to IP~3~. Here too, there was no detectable effect of the catalytic subunit of PKA on IP~3~-evoked Ca^2+^ release via IP~3~R2 (supplemental [Fig. S1](http://www.jbc.org/cgi/content/full/M109.096016/DC1)*C*). Under the same conditions, where direct activation of PKA had no effect on IP~3~-evoked Ca^2+^ release, cAMP (3 m[m]{.smallcaps}) potentiated the response to a submaximal concentration of IP~3~ (60 n[m]{.smallcaps}) to the same extent whether applied alone, or after pretreatment (10 min) with H89 (10 μ[m]{.smallcaps}), the catalytic subunit of PKA (200 units/ml) or both ([Fig. 6](#F6){ref-type="fig"}*B*). We conclude that sensitization of IP~3~R2 by cAMP occurs independently of activation of PKA.

We can only speculate on the negligible (IP~3~R1) or undetectable effect (IP~3~R2 and IP~3~R3) of PKA on IP~3~-evoked Ca^2+^ release from DT40 cells expressing homomeric IP~3~R. Association of IP~3~R with AKAP facilitates their phosphorylation by endogenous PKA ([@B40], [@B44], [@B45]), but ineffective targeting of PKA by AKAP is unlikely to prevent exogenous catalytic subunit of PKA from phosphorylating IP~3~R ([Fig. 6](#F6){ref-type="fig"} and [supplemental Fig. S1](http://www.jbc.org/cgi/content/full/M109.096016/DC1)). Accessory proteins, perhaps analogous to the IP~3~R-associated cGMP kinase substrate (IRAG) required for regulation of IP~3~R by cGMP-dependent protein kinase ([@B46]), may be required for PKA to modulate IP~3~R activity. IP~3~R may already be phosphorylated in DT40 cells, although the lack of effect of PKA in permeabilized cells after sustained pretreatment of intact cells with an inhibitor of PKA suggests this is unlikely ([supplemental Fig. S1](http://www.jbc.org/cgi/content/full/M109.096016/DC1)*C*). Furthermore, even when IP~3~R3 was shown to be phosphorylated by PKA in DT40 cells, there was no change in their response to IP~3~ ([@B27]). A further possibility is that an active protein phosphatase is associated with IP~3~R ([@B32], [@B47]) and limits their steady-state phosphorylation in DT40 cells.

The essential point for the present discussion is that cAMP directly potentiates IP~3~-evoked Ca^2+^ release and the effect is both more substantial than, and independent of, the effects of phosphorylation by PKA.

#### Loss of Gα~s~ Attenuates Sensitization of IP~3~ Receptors by PTH

Potentiation of CCh-evoked Ca^2+^ signals by forskolin or PTH requires an intimate association between IP~3~R2 and AC6 that allows cAMP to pass directly to the IP~3~R ([@B7]) ([Fig. 1](#F1){ref-type="fig"}*A*). Subsequent experiments seek to establish whether Gα~s~, which links PTH receptors to activation of AC, is also specifically associated with these AC·IP~3~R junctions.

We established seven stable HEK-PR1 cell lines in which shRNA was used to reduce expression of Gα~s~ (HEK-PR1α~s~^−^ cells) and three mock transfected lines. The responses of the latter to CCh alone or with PTH were indistinguishable from the parental cells (not shown). Results are shown for only one of the HEK-PR1α~s~^−^ lines, in which Gα~s~ expression was reduced by \>95% ([@B7]). The concentration-dependent effects of CCh alone or with PTH on Ca^2+^ signals were similar in each of the other HEK-PR1α~s~^−^ lines. Neither the Ca^2+^ signals evoked by CCh alone ([@B7]), their potentiation by forskolin ([Fig. 7](#F7){ref-type="fig"}*A*), nor forskolin-stimulated cAMP production ([Fig. 7](#F7){ref-type="fig"}*B*) was affected by loss of Gα~s~. This establishes that selection of the stable HEK-PR1α~s~^−^ cells had no effect on AC activity, CCh-mediated Ca^2+^ signaling, or potentiation of IP~3~R activity by cAMP.

![**Loss of Gα~s~ attenuates PTH-potentiated Ca^2+^ signals.** *A* and *B*, concentration-dependent effects of forskolin on the potentiation of the Ca^2+^ release evoked by CCh (1 m[m]{.smallcaps}) (*A*) and on the increase in cAMP production measured 30 s after stimulation of HEK-PR1 and HEK-PR1α~s~^−^ cells (*B*). *C*, concentration-dependent effects of PTH on cAMP formation (measured after 30 s) in HEK-PR1 and HEK-PR1α~s~^−^ cells alone or after pre-incubation (20 min) with SQ 22536 (SQ, 1 m[m]{.smallcaps}) and 2′,5′-dideoxyadenosine (DDA, 200 μ[m]{.smallcaps}) (SQ/DDA). *D*, cells treated as in *C* (with the same *symbols*) but showing the effects of PTH on CCh-evoked Ca^2+^ signals. Results (*A--D*) are means ± S.E., *n* ≥ 3.](zbc0211014470007){#F7}

To allow direct comparison between PTH-evoked Ca^2+^ and cAMP signals, we measured both responses under the same conditions, after identical intervals (30 s) and in the absence of 3-isobutylmethylxanthine (see "Experimental Procedures"). Under these conditions, PTH caused a concentration-dependent stimulation of AC activity in both HEK-PR1 and HEK-PR1α~s~^−^ cells ([Fig. 7](#F7){ref-type="fig"}*C*). Loss of Gα~s~ caused the EC~50~ for PTH-evoked cAMP formation to increase by at least 10-fold ([Fig. 7](#F7){ref-type="fig"}*C*), while the maximal response (to 1 μ[m]{.smallcaps} PTH) was reduced by 61 ± 7% and then reduced further (by 90 ± 5%) when AC was inhibited by SQ 22536 (1 m[m]{.smallcaps}) with DDA (200 μ[m]{.smallcaps}) (SQ/DDA). In HEK-PR1 cells, inhibition of AC by SQ/DDA more fully inhibited PTH-evoked cAMP formation (81 ± 5%) than did loss of Gα~s~ (61 ± 7%) ([Fig. 7](#F7){ref-type="fig"}*C*).

Inhibition of AC alone had no effect on PTH-potentiated Ca^2+^ signals ([Fig. 7](#F7){ref-type="fig"}*D*) ([@B7]), but loss of Gα~s~ reduced their peak amplitude without affecting their sensitivity to PTH ([Fig. 7](#F7){ref-type="fig"}*D* and [Table 2](#T2){ref-type="table"}). We confirmed, using single cell analyses of \[Ca^2+^\]*~i~*, that the same fraction of cells responded to PTH in normal and Gα~s~-deficient cells, that the two cell lines responded similarly to CCh alone, and that the amplitude of the PTH-potentiated CCh-evoked Ca^2+^ signal was decreased by 29 ± 4% in HEK-PR1α~s~^−^ cells ([Table 2](#T2){ref-type="table"}). This demonstrates that the results with cell populations, where loss of Gα~s~ diminished peak PTH-evoked Ca^2+^ signals by 34 ± 3% ([Fig. 7](#F7){ref-type="fig"}*D*), do not arise from an all-or-nothing loss of responsiveness of individual cells. For each cell, therefore, loss of \>95% of Gα~s~ caused a ∼30% decrease in the peak Ca^2+^ signals evoked by PTH.

###### 

**Potentiation of CCh-evoked Ca^2+^ signals by PTH in Gα~s~-deficient cells**

The EC~50~ values for potentiation of CCh-evoked Ca^2+^ release by PTH or forskolin in populations of HEK-PR1 cells are shown. Results are means ± S.E., *n* ≥ 3. Single cells loaded with fura-2 were stimulated with CCh alone (1 m[m]{.smallcaps}) followed by PTH (100 n[m]{.smallcaps}) in the continued presence of CCh. Responses from 6--12 independent coverslips, each including 116--233 cells, were analyzed. The results show the increase in \[Ca^2+^\]*~i~* and the fraction of responsive cells in HEK-PR1 and HEK-PR1α~s~^−^ cells.

                                                  HEK-PR1                                                         HEK-PR1α~s~^−^
  ----------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------
  **Cell populations**                                                                                            
      PTH                                         52 ± 10 n[m]{.smallcaps}                                        62 ± 11 n[m]{.smallcaps}[^*a*^](#TF2-1){ref-type="table-fn"}
      PTH + H89                                   ND[^*b*^](#TF2-2){ref-type="table-fn"}                          46 ± 12 n[m]{.smallcaps}
      PTH + SQ/DDA                                ND[^*b*^](#TF2-2){ref-type="table-fn"}                          219 ± 27 n[m]{.smallcaps}[^*a*^](#TF2-1){ref-type="table-fn"}
      Forskolin                                   30 ± 6 μ[m]{.smallcaps}                                         28 ± 5 μ[m]{.smallcaps}
                                                                                                                  
  **Single cells**                                                                                                
      Initial response to CCh, Δ\[Ca^2+^\]*~i~*   585 ± 17 n[m]{.smallcaps}                                       593 ± 13 n[m]{.smallcaps}
      PTH then CCh, Δ\[Ca^2+^\]*~i~*              257 ± 32 n[m]{.smallcaps}[^*c*^](#TF2-3){ref-type="table-fn"}   183 ± 11 n[m]{.smallcaps}[^*c*^](#TF2-3){ref-type="table-fn"}
      Cells responding to PTH then CCh            95 ± 1%                                                         91 ± 3%

*^a^ p* \< 0.05 (between marked values).

*^b^* ND, not determined.

*^c^ p* \< 0.05 (between marked values).

These results establish that the ability of all concentrations of PTH to potentiate CCh-evoked Ca^2+^ signals is insensitive to a uniform ∼80% inhibition of AC activity by low affinity inhibitors of AC (SQ/DDA). But a lesser inhibition of AC arising from loss of Gα~s~ attenuates PTH-mediated Ca^2+^ signaling ([Fig. 7](#F7){ref-type="fig"}*D*). Why should inhibition of AC activity by loss of Gα~s~ more effectively inhibit PTH-mediated Ca^2+^ signaling than direct inhibition of AC by low affinity inhibitors?

#### Association of Gα~s~ with AC·IP~3~R Junctions

Earlier experiments comparing the effects of inhibiting AC by reducing its expression with RNA interference or by inhibition of AC with SQ/DDA revealed a similar phenomenon to that observed with loss of Gα~s~. Complete inhibition of AC within individual AC·IP~3~R junctions by selective inhibition of AC6 expression attenuated PTH-evoked Ca^2+^ signaling. However, a greater, but uniformly distributed, inhibition by low affinity inhibitors of AC (SQ/DDA) had no effect on Ca^2+^ signaling ([@B7]). These and related results lead to our conclusion that the AC·IP~3~R junction ([Fig. 1](#F1){ref-type="fig"}*A*) is the minimal signaling unit and that within it cAMP is delivered to IP~3~R at concentrations greater than are needed maximally to sensitize associated IP~3~R. Each junction operates with a substantial "safety margin." Removing AC from individual junctions (by inhibition of AC expression) incapacitates individual junctions, whereas SQ/DDA uniformly attenuates cAMP formation at each junction, but the lesser amount of cAMP made within each is still sufficient to sustain effective communication between AC and IP~3~R ([@B7]).

Attenuation of the responses to PTH by loss of Gα~s~ might result entirely from the diminished activity of AC, or it might reflect an additional stimulatory role for Gs in modulating responses of IP~3~R to cAMP. We previously demonstrated that the maximal effects of 8-Br-cAMP and PTH on the sensitivity of Ca^2+^ release to CCh were the same, and the two stimuli together had no greater effect ([@B7]). This provided persuasive evidence that cAMP alone mediates the effects of PTH on IP~3~R sensitivity. That conclusion is further supported by the results shown in [Fig. 8](#F8){ref-type="fig"}*A*, in which we compare the amounts of cAMP associated with comparable Ca^2+^ signals evoked by PTH under different conditions. The comparison is reasonable, because cAMP and \[Ca^2+^\]*~i~* are measured at the same time (30 s) under identical conditions, and single cell analyses confirm that all cells respond similarly ([Table 2](#T2){ref-type="table"}). Comparably potentiated Ca^2+^ signals are associated with larger amounts of cAMP in normal HEK-PR1 cells than in HEK-PR1α~s~^−^ cells. These results, where cells with most Gα~s~ appear least sensitive to cAMP, are inconsistent with Gα~s~ potentiating the responses of IP~3~R to cAMP. These results reinforce our initial conclusion that cAMP alone mediates the effects of PTH on IP~3~R ([@B7]).

![**Association of Gα~s~ with AC·IP~3~R junctions.** *A*, from the results shown in [Fig. 7](#F7){ref-type="fig"}, *C* and *D*, the relationships between the change in cAMP content and potentiation of CCh-evoked Ca^2+^ signals by PTH are shown for HEK-PR1 and HEK-PR1α~s~^−^ cells alone or after pretreatment with SQ/DDA (20 min). The *right panel* shows an enlarged version of the relationship for the lower ΔcAMP levels. Results are means ± S.E., *n* ≥ 3. *B*, proposed arrangement of AC·IP~3~R junctions. The *central panel* shows the signaling proteins that regulate the AC·IP~3~R junction, allowing AC6 to deliver super-saturating concentrations of cAMP to an associated IP~3~R2. The predicted consequences of incompletely inhibiting AC with low affinity inhibitors (SQ/DDA, *right*) or diminishing AC activity by removal of Gα~s~ from AC·IP~3~R junctions (shRNA, *left*) are shown. As long as some Gα~s~ remains associated with the junction, the cAMP safety margin allows effective signaling to the IP~3~R (*upper left*), but complete removal of Gα~s~ from a junction incapacitates signaling (*lower left*). We speculate that ∼22 Gα~s~ associate with each AC·IP~3~R junction (see text). Whether PTH receptors associate specifically with individual junctions has not yet been addressed.](zbc0211014470008){#F8}

Although cAMP is the only signal through which PTH communicates with IP~3~R, the effective cAMP cannot be uniformly distributed, because otherwise the effects of inhibiting cAMP formation should be identical whatever step in the signaling pathway is targeted for inhibition. We speculate that a small number of Gα~s~ are specifically associated with each AC·IP~3~R junction ([Fig. 8](#F8){ref-type="fig"}*B*). Random removal of Gα~s~ from the signaling complex (by inhibition of Gα~s~ expression) inactivates signaling from PTH to a complex without Gα~s~, whereas complexes with residual Gα~s~ continue to function, albeit with a lesser cAMP "safety margin" ([Fig. 8](#F8){ref-type="fig"}*B*, *upper left*) than normal junctions. Hence, for HEK-PR1α~s~^−^ cells, PTH-potentiated Ca^2+^ signals are associated with lesser overall increases in cAMP than in HEK-PR1 cells ([Fig. 8](#F8){ref-type="fig"}*A*). The maximal potentiated Ca^2+^ signal evoked by PTH is decreased by 30% in HEK-PR1α~s~^−^ cells, even though lesser amounts of cAMP in normal cells with AC inhibited by SQ/DDA are associated with undiminished Ca^2+^ signals ([Fig. 7](#F7){ref-type="fig"}*D*). These results suggest that the ≥95% knockdown of Gα~s~ inactivates signaling by PTH to ∼30% of the AC·IP~3~R junctions. Assuming that a single Gα~s~ is sufficient to mediate effective transmission to an AC·IP~3~R junction and that the 95% loss of Gα~s~ is randomly distributed among the junctions, we predict ([supplemental text](http://www.jbc.org/cgi/content/full/M109.096016/DC1)) that there is an average of 1.1 Gα~s~ within each functional synapse of Gα~s~-deficient cells, and ∼22 Gα~s~/synapse in normal cells.

#### Conclusions: Structure and Function of AC·IP~3~R Junctions

We have shown that all three IP~3~R subtypes are directly regulated by cAMP binding either directly to the IP~3~R or to a protein tightly associated with it ([Figs. 1](#F1){ref-type="fig"}[](#F2){ref-type="fig"}[](#F3){ref-type="fig"}--[4](#F4){ref-type="fig"}). The effect of cAMP, which increased the efficacy of IP~3~ ([Fig. 4](#F4){ref-type="fig"}), required neither PKA ([Fig. 6](#F6){ref-type="fig"}) nor the site through which ATP modulated IP~3~R2 activity ([Figs. 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). In HEK cells, we have established that a specific association of IP~3~R2 with AC6 allows cAMP to pass directly from AC to the IP~3~R within an AC·IP~3~R junction ([Fig. 8](#F8){ref-type="fig"}*B*) ([@B7]). This "binary mode" of cAMP signaling ([Fig. 1](#F1){ref-type="fig"}*A*) allows robust communication between cell surface receptors and IP~3~R, because each AC·IP~3~R junction operates as an on-off switch with a large safety margin. The similar sensitivity of all IP~3~R to cAMP ([Fig. 2](#F2){ref-type="fig"}) suggests that the specific requirement for IP~3~R2 in HEK cells derives from IP~3~R2 selectively associating with AC6 to form the junctions required to deliver cAMP at sufficient concentration to regulate IP~3~R. Results from cells with much reduced expression of Gα~s~ ([Figs. 7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}) suggest that small numbers of Gα~s~ (∼22 α~s~/AC·IP~3~R junction) may also associate with the AC·IP~3~R junction ([Fig. 8](#F8){ref-type="fig"}*B*).

IP~3~ and cAMP are ubiquitous intracellular messengers, and interactions between them are common. Here we demonstrate another level of interaction in which cAMP itself sensitizes each IP~3~R subtype by increasing the efficacy of IP~3~. The interaction is not mediated by PKA, nor does it involve the ATP-binding site of the IP~3~R. It remains to be resolved whether cAMP binds directly to IP~3~R or to a tightly associated accessory protein. Within intact HEK cells, a selective association of IP~3~R2 with AC6 to form an AC·IP~3~R junction ([Fig. 1](#F1){ref-type="fig"}*A*) allows cAMP preferentially to regulate IP~3~R2. The G-protein, G~s~, that couples PTH to stimulation of AC, appears also to selectively associate with the AC·IP~3~R signaling junction. Aside from defining a novel interaction between cAMP and Ca^2+^ signaling pathways, our results highlight the importance of the spatial organization of both pathways in mediating effective signal transduction.

Supplementary Material
======================

###### Supplemental Data

This work was supported in part by The Wellcome Trust (Grant 085295), the Medical Research Council, UK (Grant G0700843), and the Biotechnology and Biological Sciences Research Council, UK (Grant BB/E004660/1).

The on-line version of this article (available at <http://www.jbc.org>) contains supplemental [Fig. S1](http://www.jbc.org/cgi/content/full/M109.096016/DC1), [Table S1](http://www.jbc.org/cgi/content/full/M109.096016/DC1) and supplemental [Experimental Procedures](http://www.jbc.org/cgi/content/full/M109.096016/DC1), [Discussion](http://www.jbc.org/cgi/content/full/M109.096016/DC1), and an additional [reference](http://www.jbc.org/cgi/content/full/M109.096016/DC1).

The abbreviations used are: PTHresidues 1--34 of human parathyroid hormoneACadenylyl cyclaseAC6type 6 adenylyl cyclase*B*~max~maximal concentration of binding sites\[Ca^2+^\]*~i~*intracellular free Ca^2+^ concentrationCChcarbamylcholine chlorideCLMcytosol-like mediumDDA2′,5′-dideoxyadenosineEC~50~half-maximally effective concentrationH89*N*-\[2-((*p*-bromocinnamyl)amino)ethyl\]-5-isoquinoline sulfonamideHBSHEPES-buffered salineHEK-PR1 (HEK-PR1α~s~^−^)human embryonic kidney cells stably expressing human type 1 PTH receptor (and also stably expressing shRNA for α~s~)IP~3~inositol 1,4,5-trisphosphateIP~3~RIP~3~ receptorORFopen reading framePKAprotein kinase A (cAMP-dependent protein kinase)PSpipette solutionshRNAshort hairpin RNASQ 225369-(tetrahydro-2′-furyl)adenineSQ/DDA1 m[m]{.smallcaps} SQ 22536 with 200 μ[m]{.smallcaps} DDA (used to inhibit AC)BAPTA1,2-bis(2-aminophenoxy)ethane-*N*,*N*,*N*′,*N*′-tetraacetic acidATPBB binding site for ATP in IP~3~R2.

We thank Dr. F. Wolfram (Cambridge) for completing preliminary functional analyses of Sf9 cells, and Drs. D. Yule (Rochester) and K. Mikoshiba (Tokyo) for kind gifts of DT40ΔATPB cells and plasmid encoding mouse IP~3~R2, respectively.

[^1]: A Drapers\' research fellow at Pembroke College, Cambridge.
